Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$261M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$241M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$234M |
| 4 |
Keurig Dr Pepper
KDP
|
+$173M |
| 5 |
FedEx
FDX
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Healthcare | 7.18% |
| 3 | Consumer Discretionary | 7.09% |
| 4 | Financials | 5.3% |
| 5 | Industrials | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMPE
4251
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $434K | ﹤0.01% |
910
+876
| +2,576% | +$287K |
|
4252
Corvus Pharmaceuticals
CRVS
$1.22B
| $433K | ﹤0.01% |
121,618
-259,525
| -68% | -$1.05M |
|
4253
Nuveen Preferred & Income Opportunities Fund
JPC
$2.83B
| $433K | ﹤0.01% |
+45,615
| New | +$405K |
|
4254
Mercury Insurance
MCY
$5.79B
| $432K | ﹤0.01% |
8,281
-117,697
| -93% | -$5.26M |
|
4255
CALL
Eastman Chemical
EMN
$8.23B
| $431K | ﹤0.01% |
+4,300
| New | +$399K |
|
|
4256
PUT
Eastman Chemical
EMN
$8.23B
| $431K | ﹤0.01% |
+4,300
| New | +$399K |
|
4257
Theravance Biopharma
TBPH
$884M
| $431K | ﹤0.01% |
24,252
+7,584
| +46% | +$136K |
|
4258
Mastech Digital
MHH
$91.1M
| $430K | ﹤0.01% |
+27,015
| New | +$488K |
|
4259
Smart Sand
SND
$199M
| $430K | ﹤0.01% |
250,096
+25,635
| +11% | +$41.8K |
|
4260
Actinium Pharmaceuticals
ATNM
$33.9M
| $429K | ﹤0.01% |
+55,020
| New | +$598K |
|
4261
Opko Health
OPK
$1.11B
| $428K | ﹤0.01% |
108,266
+57,295
| +112% | +$239K |
|
4262
Columbia Banking Systems
COLB
$8.64B
| $427K | ﹤0.01% |
11,896
-22,857
| -66% | -$709K |
|
|
MRUS
4263
DELISTED
Merus
MRUS
| $427K | ﹤0.01% |
24,378
-25,249
| -51% | -$373K |
|
4264
PUT
Strategy Inc
MSTR
$50.4B
| $427K | ﹤0.01% |
+11,000
| New | +$257K |
|
|
AAN
4265
DELISTED
The Aaron's Company Inc
AAN
| $427K | ﹤0.01% |
+22,519
| New | +$415K |
|
|
LDL
4266
DELISTED
Lydall, Inc.
LDL
| $427K | ﹤0.01% |
+14,228
| New | +$342K |
|
4267
Omega Flex
OFLX
$272M
| $426K | ﹤0.01% |
+2,920
| New | +$461K |
|
|
CCC
4268
CALL
CCC Intelligent Solutions
CCC
$4.39B
| $425K | ﹤0.01% |
+32,000
| New | +$390K |
|
|
DMTK
4269
DELISTED
DermTech, Inc. Common Stock
DMTK
| $425K | ﹤0.01% |
+13,095
| New | +$186K |
|
|
JRO
4270
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $425K | ﹤0.01% |
+49,029
| New | +$409K |
|
4271
Tecnoglass Holdings
TGLS
$1.79B
| $424K | ﹤0.01% |
+61,414
| New | +$367K |
|
|
ROIC
4272
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $424K | ﹤0.01% |
31,631
-408,689
| -93% | -$5M |
|
4273
Alto Ingredients
ALTO
$309M
| $423K | ﹤0.01% |
77,878
+63,150
| +429% | +$438K |
|
4274
Chemed
CHE
$7.11B
| $423K | ﹤0.01% |
794
-27,094
| -97% | -$13.3M |
|
4275
Advanced Energy
AEIS
$11B
| $422K | ﹤0.01% |
4,348
-34,533
| -89% | -$2.94M |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 71% from $81.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $41.4B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $261M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 71% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.